Achieve Life Sciences

$11.24
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.13%) As of 6:20 PM UTC today

Why Robinhood?

You can buy or sell ACHV and other stocks, options, and ETFs commission-free!

About ACHV

Achieve Life Sciences, Inc. Common Shares, also called Achieve Life Sciences, is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada. The listed name for ACHV is Achieve Life Sciences, Inc. Common Shares.

CEO
John A. Bencich
Employees
14
Headquarters
Vancouver, British Columbia
Founded
1991
Market Cap
39.94M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
179.67K
High Today
$11.32
Low Today
$10.59
Open Price
$11.25
Volume
148.56K
52 Week High
$18.26
52 Week Low
$4.51

ACHV Earnings

-$2.47
-$1.65
-$0.82
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 12, After Hours

You May Also Like

AXU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure